Hillsdale Investment Management Inc. Artivion, Inc. Transaction History
Hillsdale Investment Management Inc.
- $1.79 Billion
- Q4 2024
A detailed history of Hillsdale Investment Management Inc. transactions in Artivion, Inc. stock. As of the latest transaction made, Hillsdale Investment Management Inc. holds 220 shares of AORT stock, worth $5,517. This represents 0.0% of its overall portfolio holdings.
Number of Shares
220
Previous 270
18.52%
Holding current value
$5,517
Previous $7,000
14.29%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding AORT
# of Institutions
176Shares Held
37.1MCall Options Held
29.9KPut Options Held
2.3K-
Black Rock Inc. New York, NY6.64MShares$166 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.8MShares$70.3 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY2.79MShares$70.1 Million2.68% of portfolio
-
Macquarie Group LTD Australia, C32.74MShares$68.7 Million0.09% of portfolio
-
Morgan Stanley New York, NY2.36MShares$59.2 Million0.0% of portfolio
About ARTIVION, INC.
- Ticker AORT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 40,316,100
- Market Cap $1.01B
- Description
- Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...